GERALD SIMONS: Open Payments
NPI 1720139124 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 8 payments from 5 companies in 2025. Trend: 2023 $80 · 2024 $135 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $22 |
Products named: XIFAXAN, Auvelity, HYQVIA, NUZYRA, Tirosint.
Industry payments across NY — which companies pay providers there.
